IGM Biosciences Presents Data from T cell Engager Portfolio
First Preclinical Data for IGM-2644 and IGM-2537 Featured in Poster Presentations ...
Source: globenewswire.com
Stay updated with breaking news from Demonstrates Potent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First Preclinical Data for IGM-2644 and IGM-2537 Featured in Poster Presentations ...
IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update - Data from T cell Engager Portfolio for Hematologic Malignancies, Including First... | November 3, 2022